Mar 15, 2023 / 04:40PM GMT
Jay Olson - Oppenheimer & Co. Inc. - Analyst
Hello, everyone, and welcome to Oppenheimer's 33rd annual healthcare conference. I'm Jay Olson, one of the biotech analysts at Oppenheimer. And I want to thank you all for joining us here today.
It's a pleasure to welcome BioVie to our conference, and it's an honor to introduce Cuong Do, the CEO. Thank you so much for joining us today, Cuong.
Cuong Do - BioVie Inc. - President & CEO
Thank you so much for having me with you today.
Jay Olson - Oppenheimer & Co. Inc. - Analyst
Absolutely, our pleasure. It's always great to catch up with you. And I'll turn it over to you for your presentation, and I'll come back at the end, and see if we have any question.
Cuong Do - BioVie Inc. - President & CEO
All right. Terrific. Thank you, everyone, for joining us today. I'll just try spend about 20-25 minutes or so giving you our story, then I'll save some time for Q&A at the end. So, please queue up your questions.
BioVie Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot